Mukun Zhang

MiR-374b re-sensitizes hepatocellular carcinoma cells to sorafenib therapy by antagonizing PKM2-mediated glycolysis pathway.

Zhiyong Zhang, Heng Zhang, Mukun Zhang, 2019, American journal of cancer research.

miR-181d and c-myc-mediated inhibition of CRY2 and FBXL3 reprograms metabolism in colorectal cancer

Xinya Hong, Xingfeng Qiu, Xiao-Zhong Guo, 2017, Cell Death and Disease.

METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes

Zhiyong Zhang, Junfei Jin, Hui-wen Song, 2019, Autophagy.